Organic Process Research & Development 2010, 14, 1177–1181
Amide Bond Formation via Reversible, Carboxylic Acid-Promoted Lactone Aminolysis
Megan A. Foley and Timothy F. Jamison*
Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, U.S.A.
Abstract:
inexpensive reagents and catalysts, (d) minimal solvent usage,
and (e) a nonchromatographic purification. The closest precedent
to this approach involves prolonged heating of the lactone 2
and amine 4 in the presence of 2-hydroxypyridine (5) and
triethylamine, either neat4 or using tert-butylmethyl ether as a
solvent (Scheme 1).5
A rapid carboxylic acid-promoted lactone aminolysis is reported.
A number of carboxylic acids were found to promote this amide
bond-forming transformation, with aliphatic acids being the most
efficient. This reaction is an equilibrium process (Keq ≈ 1.8), and
mechanistic investigations are consistent with mediation of
a kinetically important proton-transfer step by the car-
boxylate, i.e., the conjugate base of the acid employed.
Scheme 1. Direct, aminolytic lactone ring-opening
Introduction
Aliskiren (1) is the first orally available renin inhibitor
approved by the FDA for the treatment of hypertension (Figure
1). Recently our laboratory has become interested in multistep,
continuous flow chemical synthesis.1 We selected 1 as a test
case for the development of a robust continuous manufacturing
process, beginning with an advanced intermediate and culminat-
ing in isolation of a pure drug substance. The near-term goal
of the project is development of a synthetic route to 1 from
lactone 2 (Scheme 1) with the long-term goal of implementing
the reactions and purifications in a continuous system.
Results and Discussion
Optimization of the Lactone Aminolysis. We initially
investigated several refinements of the literature process. For
example, we screened several different catalysts6 and solvents
and found that 5 was the most efficient and that the reaction
was the fastest in the absence of solvent, but nevertheless
required 6 h to reach 73% conversion at 90 °C. Increasing the
reaction temperature to 120 °C and the stoichiometry of 4 from
3 to 5 equiv accelerated the reaction, resulting in 87%
conversion after 90 min. While this finding was promising,
2-hydroxypyridine is of low water solubility, a trait that would
complicate the purification step for a reaction in a continuous
system.
Figure 1. Aliskiren.
Aliskiren possesses a secondary amide moiety (3) that is
commonly formed via ring-opening of the corresponding lactone
(Scheme 1). Preparation of the amide from lactone 2 often
involves a multistep sequence beginning with hydrolytic lactone
opening to the corresponding acid, followed by protection of
the liberated alcohol and amide bond formation, employing a
peptide-coupling reagent.2 Alternatively, direct lactone ami-
nolysis procedures suffer from long reaction times or require
harsh reaction conditions such as, AlMe3.3 With the ultimate
goal of developing a continuous process, we set the following
as criteria for conversion of 2 to 3: (a) one chemical step, (b)
a reaction time of less than one hour, (c) the use of only
In 2001, Novartis disclosed a general lactone-opening
procedure employing a combination of sodium 2-ethylhexanoate
(Na+ salt of 6) and an ammonium chloride salt as the catalytic
system.7 These conditions seemed promising with regard to
* Author to whom correspondence may be sent. E-mail: tfj@mit.edu.
(1) Bedore, M. W.; Zaborenko, N.; Jensen, K. F.; Jamison, T. F. Org.
Process Res. DeV. 2010, 14, 432.
(4) (a) Ru¨eger, H.; Stutz, S.; Go¨schke, R.; Spindler, F.; Maibaum, J.
Tetrahedron Lett. 2000, 41, 10085. (b) Sandham, D. A.; Taylor, R. F.;
Carey, S. J.; Fa¨ssler, A. Tetrahedron Lett. 2000, 41, 10091. (c)
Dondoni, A.; De Lathauwer, G.; Perrone, D. Tetrahedron Lett. 2001,
42, 4819. (d) Herold, P.; Stutz, S.; Spindler, F. WO/02/02508, 2002.
(e) Dong, H.; Zhang, Z.-L.; Huang, J.-H.; Ma, R.; Chen, S.-H.; Li, G.
Tetrahedron Lett. 2005, 46, 6337. (f) Hanessian, S.; Guesne´, S.;
Che´nard, E. Org. Lett. 2010, 12, 1816.
(2) (a) Kempf, D. J.; de Lara, E.; Stein, H. H.; Cohen, J.; Egan, D. A.;
Plattner, J. J. J. Med. Chem. 1990, 33, 371. (b) Nadin, A.; Lo´pez,
J. M. S.; Neduvelil, J. G.; Thomas, S. R. Tetrahedron 2001, 57, 1861.
(c) Yin, T. I.; Yang, G.; Tarassishin, L.; Li, Y.-M. J. Org. Chem.
2004, 69, 7344. (d) Maibaum, J.; Stutz, S.; Go¨schke, R.; Rigollier,
P.; Yamaguchi, Y.; Cumin, F.; Rahuel, J.; Baum, H.-P.; Cohen, N.-
C.; Schnell, C. R.; Fuhrer, W.; Gruetter, M. G.; Schilling, W.; Wood,
J. M. J. Med. Chem. 2007, 50, 4832.
(5) Sedelmeier, G.; Mickel, J. S.; Ru¨eger, H. WO/2006024501, 2006.
(6) Nucleophilic catalysts examined include DMAP, DABCO, phenol,
thiophenol, PPh3, and 4-pyrrolopyridine.
(3) Lindsay, K. B.; Skrydstrup, T. J. Org. Chem. 2006, 71, 4766.
10.1021/op1001269 2010 American Chemical Society
Published on Web 08/20/2010
Vol. 14, No. 5, 2010 / Organic Process Research & Development
•
1177